Valuation: DexCom, Inc.

Market Cap 28.84B 25.27B 23.46B 21.56B 40.63B 2,783B 41.22B 280B 109B 1,362B 108B 106B 4,705B P/E 2026 *
30.5x
P/E 2027 * 25.6x
Enterprise Value 28.42B 24.9B 23.11B 21.24B 40.02B 2,742B 40.61B 275B 108B 1,342B 107B 104B 4,635B EV / Sales 2026 *
5.44x
EV / Sales 2027 * 4.73x
Free-Float
93.34%
Yield 2026 *
-
Yield 2027 * -
1 day-4.15%
1 week-2.56%
Current month+5.23%
1 month+2.61%
3 months+11.76%
6 months-4.13%
Current year+6.78%
1 week 70.73
Extreme 70.73
79.15
1 month 67.3
Extreme 67.3
79.15
Current year 56.72
Extreme 56.72
79.15
1 year 54.11
Extreme 54.11
89.98
3 years 54.11
Extreme 54.11
142
5 years 54.11
Extreme 54.11
164.86
10 years 10.66
Extreme 10.655
164.86
Manager TitleAgeSince
Chief Executive Officer 47 2025-12-31
Director of Finance/CFO 46 2021-03-18
Chief Tech/Sci/R&D Officer - 2024-04-30
Director TitleAgeSince
Chairman 68 2018-07-29
Director/Board Member 67 2009-11-19
Director/Board Member 47 2025-12-31
Date Insider Type Main position Quantity % Market Cap.
7/15/26 Sell

General Counsel

-1,700 0.0004%
7/6/26 Sell

Chairman

-26,756 0.0069%
6/15/26 Sell

General Counsel

-1,700 0.0004%
Change 5-day change 1-year change 3-year change Capi.($)
-4.23%-2.56%-16.74%-44.51% 28.84B
+0.87%+12.31%-20.26%-12.53% 174B
-0.66%+1.50%-10.88%-7.98% 105B
-0.91%+0.92%+2.16%+56.34% 58.97B
-1.59%-2.05%+36.71%+59.47% 52.24B
-0.38%-1.24%-15.62%-45.36% 42.39B
-4.75%-5.72% - - 33.05B
-0.33%-0.73%+62.81%-5.23% 25.38B
-0.63%-0.31%-5.76%-9.20% 20.64B
-1.85%-1.52%-9.08%+0.50% 20.28B
Average -1.43%+2.20%+2.59%-0.94% 56.08B
Weighted average by Cap. -0.74%+4.79%-4.68%-0.20%

Financials

2026 *2027 *
Net sales 5.22B 4.58B 4.25B 3.9B 7.36B 504B 7.47B 50.62B 19.81B 247B 19.61B 19.19B 852B 5.83B 5.11B 4.74B 4.36B 8.21B 562B 8.33B 56.46B 22.1B 275B 21.87B 21.4B 950B
Net income 959M 841M 780M 717M 1.35B 92.58B 1.37B 9.3B 3.64B 45.3B 3.6B 3.52B 156B 1.16B 1.01B 941M 865M 1.63B 112B 1.65B 11.21B 4.39B 54.65B 4.34B 4.25B 189B
Net Debt -429M -376M -349M -320M -604M -41.37B -613M -4.15B -1.63B -20.24B -1.61B -1.57B -69.93B -1.28B -1.12B -1.04B -957M -1.8B -124B -1.83B -12.41B -4.86B -60.47B -4.81B -4.7B -209B
Logo DexCom, Inc.
DexCom, Inc. specializes in the design, manufacture and marketing of continuous glucose monitoring (CGM) systems for people with diabetes and healthcare providers. The company provides an implantable device for continuous measurement of blood glucose levels and an external transmitter to which the sensor transmits glucose levels at specified intervals. The United States accounts for 71.5% of net sales.
Employees
11,050
Date Price Change Volume
26-07-22 US$71.09 -4.90% 2,111,836
26-07-21 US$74.75 -1.24% 3,962,329
26-07-20 US$75.69 -1.25% 3,188,475
26-07-17 US$76.65 -1.71% 5,069,951
26-07-16 US$77.98 +7.22% 6,640,098
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
74.75USD
Average target price
85.75USD
Spread / Average Target
+14.72%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. DXCM Stock